DARMSTADT, Germany (Reuters) - Germany's Boehringer Ingelheim priced its new stroke prevention pill at $6.75 a day, higher than some analysts expected and potentially setting a price precedent for Bayer AG (BAYGn.DE) and Johnson & Johnson (JNJ.N), who are hoping to bring a rival drug to market.
